Coronary Revascularization in Patients with CKD Stage 5D: Pragmatic Considerations

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Patients with chronic kidney disease (CKD) stage 5D face high risks of mortality and cardiovascular events, complicating revascularization decisions.
• This population exhibits unique coronary plaque characteristics, diagnostic test accuracy, and responses to revascularization, making general population data inapplicable.
• Randomized trials have excluded this high-risk group, limiting evidence-based guidance for their treatment.

Purpose of the Study:

• To review the complexities and tradeoffs in determining optimal coronary revascularization strategies for patients with CKD stage 5D.
• To highlight the differences between this population and the general population regarding coronary artery disease management.
• To discuss the limitations of current evidence, including observational studies and their inherent biases.

Main Methods:

• Review of existing observational studies comparing surgical versus percutaneous coronary revascularization outcomes in CKD stage 5D patients.
• Analysis of data regarding short-term and long-term mortality associated with different revascularization approaches.
• Evaluation of the impact of specific interventions, such as drug-eluting stents and off-pump surgery, on outcomes in this population.

Main Results:

• Observational data suggest surgical revascularization may provide long-term survival benefits but is associated with higher short-term mortality.
• Percutaneous revascularization, including with drug-eluting stents, carries a significant risk of in-stent restenosis and subsequent revascularization needs.
• Current evidence indicates no definitive benefits from off-pump coronary artery bypass surgery or the newest drug-eluting stent platforms in this cohort.

Conclusions:

• Coronary revascularization decisions for CKD stage 5D patients require careful consideration of high baseline risks and population-specific factors.
• The choice between surgical and percutaneous revascularization involves balancing long-term survival advantages against short-term mortality risks and revascularization burden.
• Further research is needed to establish definitive evidence-based guidelines for optimal revascularization strategies in this vulnerable patient group.